Trials / Recruiting
RecruitingNCT07378358
Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- First Affiliated Hospital of Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter retrospective study aims to evaluate the diagnostic and therapeutic performance of three large language models-ChatGPT, Gemini and Deepseek-using 800 archived inpatient medical records from urology departments across four tertiary hospitals. The study will focus on the accuracy and applicability of these models in disease recognition, preliminary diagnosis and treatment recommendation generation, in order to explore their potential value and limitations in supporting clinical decision-making in real-world settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Large Language Model Assessment (ChatGPT, Gemini, DeepSeek) | De-identified inpatient medical records were retrospectively collected from the urology departments of four tertiary hospitals (200 cases per site, 800 in total). Each case included standardized clinical information such as demographics, chief complaint, history of present illness, past medical history, physical examination, laboratory and imaging findings, discharge diagnosis and treatment plan. To simulate the role of an AI system in a "first-visit physician" scenario, all diagnostic conclusions, differential diagnoses and treatment plans were removed before being input into the models. Three large language models (ChatGPT, Gemini and DeepSeek) were prompted with a standardized instruction: "Based on the above clinical information, provide your preliminary diagnosis, differential diagnoses and treatment recommendations." Each model generated outputs including (i) primary and secondary diagnoses, (ii) differential diagnosis lists with reasoning and (iii) preliminary treatment suggesti |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2026-04-01
- Completion
- 2026-06-01
- First posted
- 2026-01-30
- Last updated
- 2026-01-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07378358. Inclusion in this directory is not an endorsement.